Author:
Harada H,Kizaka-Kondoh S,Li G,Itasaka S,Shibuya K,Inoue M,Hiraoka M
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference38 articles.
1. Abdollahi A, Lipson KE, Han X, Krempien R, Trinh T, Weber KJ et al. (2003). SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro. Cancer Res 63: 3755–3763.
2. Brown JM . (1999). The hypoxic cell: a target for selective cancer therapy – eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 59: 5863–5870.
3. Brown JM, Wilson WR . (2004). Exploiting tumor hypoxia in cancer treatment. Nat Rev Cancer 4: 437–447.
4. Bruick RK, McKnight SL . (2001). A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294: 1337–1340.
5. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC et al. (2000). Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel–Lindau tumor suppressor protein. J Biol Chem 275: 25733–25741.
Cited by
120 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献